CriticalMix rig

Critical Pharmaceuticals Wins Two BBSRC CASE Awards

Critical Pharmaceuticals Wins Two BBSRC CASE Awards 24/01/2008 03:35

Critical Pharmaceuticals Wins Two BBSRC CASE Awards

Critical Pharmaceuticals has been awarded two CASE awards by the Biotechnology and Biological Sciences Research Council (BBSRC). The awards will fund the training of two PhD students at the University of Nottingham starting October 2008.

The two projects that will funded are:

  • The Effect of Supercritical Fluid Processing Parameters on Product Performance – Sustained Release Biologics (Academic Supervisor – Professor Steve Howdle).
  • Supercritical Fluid Technology for Gastroretentive Formulations(Academic supervisor – Dr Snow Stolnick).

Dr Andy Naylor, Head of Process Development at Critical Pharmaceuticals said, ”We are delighted to be successful in these applications and participate in training the next generation of bioscience researchers”.

Professor Steve Howdle said, “The CASE award scheme is a fantastic opportunity for graduate students to gain experience in both academic and industrial environments.” 

CriticalMix Technology

CriticalMix rig

CriticalMix enables the manufacture of highly active sustained release depot products for bimonthly, monthly or less frequent injection.

Read more

CriticalSorb Technology

nasal device

CriticalSorb enables the non-invasive nasal delivery delivery of high-value biologic products and challenging small molecule drugs.

Read more

Dr Andy Naylor, Critical Pharmaceuticals
”We are delighted to be successful in these applications and participate in training the next generation of bioscience researchers”.